Astera Labs, Inc. (ALAB) Spending and interest coverage
- R&D / revenue · 12 months: Value 36.13%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 16.23%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 36.13% | Research and development expense / revenue. Period ending 2026-06-30. $434.25M ÷ $1.20B × 100 ≈ 36.13% |
| Stock-based compensation / revenue · 12 months | 16.23% | Share-based compensation / revenue. Period ending 2026-06-30. $195.02M ÷ $1.20B × 100 ≈ 16.23% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 434.25M USD | Research and Development Expense |
| Revenue | 1.20B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 195.02M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 273.44M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $434.25M | $1.20B | $195.02M | $273.44M | (m) | 36.13% | 16.23% | (m) | (m) |
| 2026-03-31 | $365.08M | $1.00B | $166.50M | $223.97M | (m) | 36.46% | 16.63% | (m) | (m) |
| 2025-12-31 | $304.00M | $852.52M | $160.03M | $173.42M | (m) | 35.66% | 18.77% | (m) | (m) |
| 2025-09-30 | $266.73M | $723.04M | $166.88M | $106.61M | (m) | 36.89% | 23.08% | (m) | (m) |
| 2025-06-30 | $238.46M | $605.55M | $171.67M | $42.31M | (m) | 39.38% | 28.35% | (m) | (m) |
| 2025-03-31 | $211.83M | $490.47M | $179.27M | $-21.81M | (m) | 43.19% | 36.55% | (m) | (m) |
| 2024-12-31 | $200.83M | $396.29M | $234.59M | $-116.07M | (m) | 50.68% | 59.20% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $73.41M | $115.79M | $10.68M | $-29.50M | (m) | 63.39% | 9.22% | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $73.71M | $79.87M | $30.23M | $-60.19M | (m) | 92.29% | 37.85% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MONOLITHIC POWER SYSTEMS, INC. (MPWR) | United States | $65.671B | 84.84 |
| NXP Semiconductors N.V. (NXPI) | $58.101B | 17.92 | |
| MICROCHIP TECHNOLOGY INC (MCHP) | United States | $40.549B | 103.49 |
| Credo Technology Group Holding Ltd (CRDO) | Cayman Islands | $36.813B | 72.27 |
| ON SEMICONDUCTOR CORP (ON) | United States | $28.502B | 56.37 |
| Qnity Electronics, Inc. (Q) | United States | $25.588B | 54.28 |
| MACOM Technology Solutions Holdings, Inc. (MTSI) | United States | $21.756B | 101.96 |
| SITIME Corp (SITM) | United States | $19.354B | 1,402.77 |
| FIRST SOLAR, INC. (FSLR) | United States | $18.501B | 14.52 |
| LATTICE SEMICONDUCTOR CORP (LSCC) | United States | $17.355B | 515.93 |